Surgery Partners, Inc. (SGRY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350M 700M 1.1B Q2 '16: 289.7M Q3 '16: 282.7M Q4 '16: 306M Q1 '17: 286.2M Q2 '17: 288.4M Q4 '17: 460.3M Q1 '18: 411.3M Q2 '18: 436.6M Q3 '18: 432.4M Q4 '18: 491.2M Q1 '19: 416.8M Q2 '19: 445.4M Q3 '19: 452M Q4 '19: 517.2M Q1 '20: 441M Q2 '20: 374.7M Q3 '20: 496.1M Q4 '20: 548.3M Q1 '21: 512.4M Q2 '21: 543.3M Q3 '21: 559.2M Q4 '21: 610.2M Q1 '22: 596.2M Q2 '22: 615.4M Q3 '22: 620.6M Q4 '22: 707.1M Q1 '23: 666.2M Q2 '23: 667.6M Q3 '23: 674.1M Q4 '23: 735.4M Q1 '24: 717.4M Q2 '24: 762.1M Q3 '24: 770.4M Q4 '24: 864.4M Q1 '25: 776M Q2 '25: 826.2M Q3 '25: 821.5M Q4 '25: 885M Q1 '26: 810.9M Q2 '26: 848.9M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 80M 160M 240M Q1 '19: 90.7M Q2 '19: 105M Q3 '19: 98.9M Q4 '19: 129.2M Q1 '20: 74.8M Q2 '20: 55.4M Q3 '20: 114.2M Q4 '20: 135.4M Q1 '21: 103.5M Q2 '21: 118.3M Q3 '21: 122.5M Q4 '21: 147.1M Q1 '22: 124.8M Q2 '22: 134.6M Q3 '22: 131.2M Q4 '22: 184.3M Q1 '23: 134M Q2 '23: 154.1M Q3 '23: 165.8M Q4 '23: 193.6M Q1 '24: 155.3M Q2 '24: 179.2M Q3 '24: 177.5M Q4 '24: 233.6M Q1 '25: 161.9M Q2 '25: 195.6M Q3 '25: 195.3M Q4 '25: 212.2M Q1 '26: 160.2M Q2 '26: 190.2M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

0 50M 100M 150M Q1 '16: 34.3M Q2 '16: 50.9M Q3 '16: 42.8M Q4 '16: 68.4M Q1 '17: 41.7M Q2 '17: 37.7M Q4 '17: 80.4M Q1 '18: 41.2M Q2 '18: 43.5M Q3 '18: 45M Q1 '19: 49.6M Q2 '19: 55.5M Q3 '19: 59M Q4 '19: 71.8M Q1 '20: 23.5M Q2 '20: 44.7M Q3 '20: 18.5M Q4 '20: 96.3M Q1 '21: 64.3M Q2 '21: 59.5M Q3 '21: 63.6M Q4 '21: 114.8M Q1 '22: 100.4M Q2 '22: 76.5M Q3 '22: 74.1M Q4 '22: 94.2M Q1 '23: 46.4M Q2 '23: 97.6M Q3 '23: 82.6M Q4 '23: 101.4M Q1 '24: 76M Q2 '24: 84.8M Q3 '24: 60.9M Q4 '24: 127.1M Q1 '25: 61.9M Q2 '25: 111.7M Q3 '25: 105.7M Q4 '25: 110.2M Q1 '26: 65.8M Q2 '26: 102.1M Q1 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-180M -120M -60M 0 60M 120M 180M Q2 '16: 2.1M Q3 '16: -2.3M Q4 '16: 16.9M Q1 '17: -2.8M Q2 '17: -4.5M Q4 '17: -32.2M Q1 '18: -17.5M Q2 '18: -19.5M Q3 '18: -21M Q4 '18: -147.7M Q1 '19: -20.1M Q2 '19: -19.8M Q3 '19: -15.7M Q4 '19: -19.2M Q1 '20: -27.5M Q2 '20: -32.5M Q3 '20: -61.6M Q4 '20: 5.5M Q1 '21: -21M Q2 '21: -26.9M Q3 '21: -22.9M Q4 '21: -100K Q1 '22: 12.2M Q2 '22: -18.4M Q3 '22: -25M Q4 '22: -23.4M Q1 '23: -24.9M Q2 '23: 18.9M Q3 '23: -4.9M Q4 '23: 46.7M Q1 '24: -12.4M Q2 '24: -15.5M Q3 '24: -31.7M Q4 '24: -108.5M Q1 '25: -37.7M Q2 '25: -2.5M Q3 '25: -22.7M Q4 '25: -15M Q1 '26: -35.9M Q2 '26: -15M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 250M 500M 750M Q2 '16: 208.9M Q3 '16: 201.4M Q4 '16: 214.2M Q1 '17: 211.9M Q2 '17: 216.5M Q4 '17: 338.7M Q1 '18: 327.3M Q2 '18: 340.1M Q3 '18: 334.3M Q4 '18: 359.7M Q1 '19: 326.1M Q2 '19: 340.4M Q3 '19: 353.1M Q4 '19: 388M Q1 '20: 366.2M Q2 '20: 319.3M Q3 '20: 381.9M Q4 '20: 412.9M Q1 '21: 408.9M Q2 '21: 425M Q3 '21: 436.7M Q4 '21: 463.1M Q1 '22: 471.4M Q2 '22: 480.8M Q3 '22: 489.4M Q4 '22: 522.8M Q1 '23: 532.2M Q2 '23: 513.5M Q3 '23: 508.3M Q4 '23: 541.8M Q1 '24: 562.1M Q2 '24: 582.9M Q3 '24: 592.9M Q4 '24: 630.8M Q1 '25: 614.1M Q2 '25: 630.6M Q3 '25: 626.2M Q4 '25: 672.8M Q1 '26: 650.7M Q2 '26: 658.7M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

0 70M 140M 210M Q2 '16: 48.8M Q3 '16: 18.8M Q4 '16: 32.4M Q1 '17: 34.9M Q2 '17: 21.6M Q4 '17: 54.4M Q1 '18: 30M Q2 '18: 39.6M Q3 '18: 29.5M Q4 '18: 45.5M Q1 '19: 20.5M Q2 '19: 26.7M Q3 '19: 56.9M Q4 '19: 25.4M Q1 '20: 29.2M Q2 '20: 181.9M Q3 '20: 26.9M Q4 '20: 8.9M Q1 '21: 50.2M Q2 '21: 2.3M Q3 '21: 14.9M Q4 '21: 19.7M Q1 '22: 79.8M Q2 '22: 42.1M Q3 '22: 29.7M Q4 '22: 7.2M Q1 '23: 74.5M Q2 '23: 52.1M Q3 '23: 104.6M Q4 '23: 62.6M Q1 '24: 40.7M Q2 '24: 82.8M Q3 '24: 65.2M Q4 '24: 111.4M Q1 '25: 6M Q2 '25: 81.3M Q3 '25: 83.6M Q4 '25: 103.4M Q1 '26: 11.7M Q2 '26: 59.3M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-60M 0 60M 120M 180M Q2 '16: 40.2M Q3 '16: 10.8M Q4 '16: 21.6M Q1 '17: 28.5M Q2 '17: 12.8M Q4 '17: 45.5M Q1 '18: 20M Q2 '18: 33.7M Q3 '18: 18.8M Q4 '18: 32.3M Q1 '19: 8.7M Q2 '19: 6.7M Q3 '19: 38.5M Q4 '19: 2M Q1 '20: 17.4M Q2 '20: 173.8M Q3 '20: 19M Q4 '20: -6.2M Q1 '21: 35.7M Q2 '21: -11.2M Q3 '21: -600K Q4 '21: 5.6M Q1 '22: 61.6M Q2 '22: 19.7M Q3 '22: 12.4M Q4 '22: -15.5M Q1 '23: 50.2M Q2 '23: 26.3M Q3 '23: 85.7M Q4 '23: 42.8M Q1 '24: 19.7M Q2 '24: 55.9M Q3 '24: 45M Q4 '24: 89.1M Q1 '25: -16.7M Q2 '25: 57.9M Q3 '25: 63.8M Q4 '25: 90.6M Q1 '26: -4.3M Q2 '26: 37.5M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q3 '14: 31.7M Q1 '15: 32.1M Q2 '15: 32.1M Q3 '15: 32.1M Q1 '16: 48M Q2 '16: 48.1M Q3 '16: 48M Q1 '17: 48M Q2 '17: 48.1M Q1 '18: 48M Q2 '18: 48M Q3 '18: 48M Q1 '19: 48M Q2 '19: 48.3M Q3 '19: 48.3M Q1 '20: 48.5M Q2 '20: 48.8M Q3 '20: 48.9M Q1 '21: 54.8M Q2 '21: 69.3M Q3 '21: 80.7M Q1 '22: 90.3M Q2 '22: 88.9M Q3 '22: 88.9M Q1 '23: 125.2M Q2 '23: 127.4M Q3 '23: 125.7M Q1 '24: 126M Q2 '24: 126.1M Q3 '24: 126.2M Q1 '25: 126.6M Q2 '25: 127M Q3 '25: 127.2M Q1 '26: 128.4M Q2 '26: 128.8M Q1 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '15: -2.17 Q4 '15: -0.13 Q1 '16: -0.07 Q2 '16: 0.14 Q3 '16: 0.19 Q4 '16: 0.19 Q1 '17: 0.28 Q2 '17: 0.15 Q3 '18: -2.54 Q4 '18: -4.96 Q1 '19: -5.03 Q2 '19: -5.05 Q3 '19: -4.95 Q4 '19: -2.29 Q1 '20: -2.45 Q2 '20: -2.72 Q3 '20: -3.67 Q4 '20: -3.18 Q1 '21: -2.99 Q2 '21: -2.52 Q3 '21: -1.34 Q4 '21: -1.12 Q1 '22: -0.41 Q2 '22: -0.23 Q3 '22: -0.23 Q4 '22: -0.59 Q1 '23: -0.93 Q2 '23: -0.57 Q3 '23: -0.33 Q4 '23: -0.09 Q1 '24: 0.01 Q2 '24: -0.26 Q3 '24: -0.47 Q4 '24: -1.33 Q1 '25: -1.53 Q2 '25: -1.43 Q3 '25: -1.36 Q4 '25: -0.61 Q1 '26: -0.59 Q2 '26: -0.69 Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.